Polymorphisms in the 5′- and 3′-untranslated region of the VEGF gene and sporadic breast cancer risk and clinicopathologic characteristics

Tumor Biology

Volumn 32, Issue 2, 2011, Pages 295-300

  Oliveira, Cristiane ^a   Lourenço, Gustavo J ^a   Silva, Priscilla M R ^a   Cardoso Filho, Cassio ^a   Favarelli, Maira H C ^a   Gonçales, Neiva S L ^a   Gurgel, Maria S C ^a   Lima, Carmen S P ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Angiogenesis; Breast cancer; Polymorphism; Risk; VEGF

Indexed keywords

ESTROGEN RECEPTOR; VASCULOTROPIN; VASCULOTROPIN A;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; ADULT; AGED; ARTICLE; BLOOD SAMPLING; BREAST CANCER; CANCER GRADING; CANCER RISK; CONTROLLED STUDY; DNA POLYMORPHISM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE FREQUENCY; GENE IDENTIFICATION; GENE ISOLATION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOTE; HISTOPATHOLOGY; HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; BRAZIL; BREAST TUMOR; CASE CONTROL STUDY; ETHNOLOGY; GENETIC POLYMORPHISM; GENETICS; METABOLISM; MIDDLE AGED; PAGET NIPPLE DISEASE; RISK FACTOR; UNTRANSLATED REGION;

ADULT; AGED; AGED, 80 AND OVER; BRAZIL; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; MIDDLE AGED; POLYMORPHISM, GENETIC; RECEPTORS, ESTROGEN; RISK FACTORS; UNTRANSLATED REGIONS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 79953809066     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-010-0121-x     Document Type: Article

References (31)

1. El-Gohary YM, Metwally G, Saad RS, et al. Prognostic significance of intratumoral and peritumoral lymphatic density and blood vessel density in invasive breast carcinomas. Am J Clin Pathol. 2008;8(129):578-86. (Pubitemid 352029277)
2. Berezov TT, Ovchinnikova LK, Kuznetsova OM, et al. Vascular endothelial growth factor in the serum of breast cancer patients. Bull Exp Biol Med. 2009;148:419-24.
3. Hu Z, Fan C, Livasy C, et al. A compact VEGF signature associated with distant metastases and poor outcomes. BMC Med. 2009;16:7-9.
4. Mohammed RA, Ellis IO, Elsheikh S, et al. Lymphatic and angiogenic characteristics in breast cancer: morphometric analysis and prognostic implications. Breast Cancer Res Treat. 2009;113:261-73.
5. Shivakumar S, Prabhakar BT, Jayashree K, et al. Evaluation of serum vascular endothelial growth factor (VEGF) and microvessel density (MVD) as prognostic indicators in carcinoma breast. J Cancer Res Clin Oncol. 2009;135:627-36.
6. Carpini JD, Karam AK, Montgomery L. Vascular endothelial growth factor and its relationship to the prognosis and treatment of breast, ovarian, and cervical cancer. Angiogenesis. 2010;13:43-58.
7. Safali M, Karslioǧlu Y, Arpaci F, et al. A distinct microvascular pattern accompanied by aggressive clinical course in breast carcinomas: a fact or a coincidence? Pathol Res Pract. 2010;206:93-7.
8. Renner W, Kotschan S, Hoffman C, et al. A common 936C/T mutation in the gene for vascular endothelial growth factor plasma levels. J Vasc Res. 2009;37:443-8.
9. Krippl P, Langsenlehner V, Renner W, et al. A common 936C/T gene polymorphism of vascular endothelial growth factor is associated with decrease breast cancer risk. Int J Cancer. 2003;106:469-71.
10. Jakubowska A, Gronwald J, Menkiszak J, et al. The VEGF-936-C>T 3′UTR polymorphism reduces BRCA1- associated breast cancer risk in Polish women. Cancer Lett. 2008;262:71-6.
11. Balasubramanian SP, Cox A, Cross SS, et al. Influence of VEGF-A gene variation and protein levels in breast cancer susceptibility and severity. Int J Cancer. 2007;121:1009-16. (Pubitemid 47101636)
12. Langsenlehner U, Wolf G, Langsenlehner T, et al. Genetic polymorphisms in the vascular endothelial growth factor gene and breast cancer risk. The Austrian "tumor of breast tissue: incidence, genetics, and environmental risk factors" study. Breast Cancer Res Treat. 2008;109:297-304.
13. Jin Q, Hemminki K, Enquist K, et al. Vascular endothelial growth factor polymorphism in relation to breast cancer development and prognosis. Clin Cancer Res. 2005;11:3647-53. (Pubitemid 40685580)
14. Jacobs EJ, Feigelson HS, Bain EB, et al. Polymorphisms in the vascular endothelial growth factor gene and breast cancer in the Cancer Prevention Study II cohort. Breast Cancer Res. 2006;8: R22-7.
15. Kataoka N, Cai Q, Wen W, et al. Population-based case-control study of VEGF gene polymorphism and breast cancer risk among Chinese women. Cancer Epidemiol Biomark Prev. 2006;15:1148-52.
16. Schneider BP, Radovich M, Sledge GW, et al. Association of polymorphisms of angiogenesis genes with breast cancer. Breast Cancer Res Treat. 2008;111:157-63. (Pubitemid 352009224)
17. Gu D, Wang M (2010) VEGF 936C>T polymorphism and breast cancer risk: evidence from 5,729 cases and 5,868 controls. Breast Cancer Res Treat 19. doi:10.1007/s10549-010-0991-z
18. Xu B, Li JM, Tong N, et al. VEGFA +936C>T polymorphism and cancer risk: a meta-analysis. Cancer Genet Cytogenet. 2010;198:7-14.
19. Eroglu A, Oztürk A, Cam R, et al. Vascular endothelial growth factor gene 936C/T polymorphism in breast cancer patients. Med Oncol. 2005;25:54-5.
20. Lin GT, Tseng HF, Yang CH, et al. Combinational polymorphisms of seven CXCL12-related genes are protective against breast cancer in Taiwan. OMICS. 2009;13:165-72.
21. Watson CJ, Webb NJ, Bottomley MJ, et al. Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: correlation with variation in VEGF protein production. Cytokine. 2000;12:1232-5. (Pubitemid 30611801)
22. Awata T, Inoue K, Kurihara S, et al. A common polymorphism in the 5′-untranslated region of the VEGF gene is associated with diabetic retinopathy in the type 2 diabetes. Diabetes. 2002;51:1635-9. (Pubitemid 34826636)
23. Brasil. Instituto Nacional de Câncer. Incidência de Câncer no Brasil. Estimativa 2010. Publishing Ministério da Saúde http://www.inca.gov.br/estimativa/2010
24. Muniz JJ, Izidoro-Toledo TC, Metzger IF, et al. Interethnic differences in the distribution of clinically relevant vascular endothelial growth factor genetic polymorphisms. DNA Cell Biol. 2009;28:567-72.
25. Alves-Silva J, Da Silva-Santos M, Guimarães, et al. The ancestry of Brazilian mtDNA lineages. Am J Hum Genet. 2009;67:444-61.
26. Carvalho-Silva DR, Santos FR, Rocha J, et al. The phylogeography of Brazilian Y-chromosome lineages. Am J Hum Genet. 2001;68:281-6. (Pubitemid 32049046)
27. Yang DS, Park KH, Woo OH, Woo SU et al (2010) Association of a vascular endothelial growth factor gene 936C/T polymorphism with breast cancer risk: a meta-analysis. Breast Cancer Res Treat 21. doi:10.1007/s10549-010-1070-1
28. Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology. 1991;19:403-10.
29. Greene FL, Page DL, Fleming ID, et al. Breast. In: Balch CM, editor. AJCC Cancer staging manual. 6th ed. New York: Springer; 2002. p. 223-40.
30. Papazoglou D, Galazios G, Koukourakis MI, et al. Vascular endothelial growth factor gene polymorphisms and pre-eclampsia. Mol Hum Reprod. 2000;10:321-4.
31. Losordo DW, Isner JM. Estrogen and angiogenesis: a review. Arterioscler Thromb Vasc Biol. 2001;21:6-12. (Pubitemid 32061922)